ID JOS-bpb.b18-00831
著者:名前 著者:別形式 Naito, Kota / Kurihara, Kazuki / Moteki, Hajime / Kimura, Mitsutoshi / Natsume, Hideshi / Ogihara, Masahiko
著者:カナ 著者:所属 城西大学薬学部臨床薬理学 / 城西大学薬学部臨床薬理学 / 城西大学薬学部臨床薬理学 / 城西大学薬学部臨床薬理学 / 城西大学薬学部製剤学 /城西大学薬学部臨床薬理学
著者:所属(別形式) Josai University, Faculty of Pharmaceutical Sciences, Departments of Clinical Pharmacology / Josai University, Faculty of Pharmaceutical Sciences, Departments of Clinical Pharmacology / Josai University, Faculty of Pharmaceutical Sciences, Departments of Clinical Pharmacology / Josai University, Faculty of Pharmaceutical Sciences, Departments of Clinical Pharmacology / Josai University, Faculty of Pharmaceutical Sciences, Department of Pharmaceutics /Josai University, Faculty of Pharmaceutical Sciences, Departments of Clinical Pharmacology
著者版フラグ publisher
出版地 東京
出版者 日本薬学会
出版者:カナ ニホンヤクガクカイ
出版者:別名 The Pharmaceutical Society of Japan
NCID AA10885497
冊子ISSN 09186158
電子ISSN 13475215
掲載誌名 巻 42
号 4
刊行年月 2019-04
開始ページ 631
終了ページ 637
コンテンツ作成日 2018-10-24
コンテンツ修正日 2019-01-07
コンテンツ登録日 2019-07-30
識別番号:DOI info:doi/10.1248/bpb.b18-00831
識別番号:DOI(リンク) PubMed番号 30713268
抄録 Serotonin (5-hydroxytryptamine; 5-HT) can induce hepatocyte DNA synthesis and proliferation by autocrine secretion of transforming growth factor (TGF)-α through 5-HT2B receptor/phospholipase C (PLC)/Ca2+ and a signaling pathway involving epidermal growth factor (EGF)/TGF-α receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase 2 (ERK2)/mammalian target of rapamycin (mTOR). In the present study, we investigated whether 5-HT or a selective 5-HT2B receptor agonist BW723C86, would stimulate phosphorylation of TGF-α RTK and ribosomal p70 S6 kinase (p70S6K) in primary cultures of adult rat hepatocytes. Western blotting analysis was used to detect 5-HT- or BW723C86 (10−6 M)-induced phosphorylation of EGF/TGF-α RTK and p70S6K. Our results showed that 5-HT- or BW723C86 (10−6 M)-induced phosphorylation of EGF/TGF-α RTK peaked at between 5 and 10 min. On the other hand, 5-HT- or BW723C86 (10−6 M)-induced phosphorylation of p70S6K peaked at about 30 min. Furthermore, a selective 5-HT2B receptor antagonist LY272015, a specific PLC inhibitor U-73122, a membrane-permeable Ca2+ chelator BAPTA/AM, an L-type Ca2+ channel blocker verapamil, somatostatin, and a specific p70S6K inhibitor LY2584702 completely abolished the phosphorylation of p70S6K induced by both 5-HT and BW723C86. These results indicate that phosphorylation of p70S6K is dependent on the 5-HT2B-receptor-mediated autocrine secretion of TGF-α. In addition, these results demonstrate that the hepatocyte proliferating action of 5-HT and BW723C86 are mediated by phosphorylation of p70S6K, a downstream element of the EGF/TGF-α RTK signaling pathway.
キーワード 言語 eng
資源タイプ text
ジャンル フォーマット application/pdf
権利 Copyright © 2019 The Pharmaceutical Society of Japan
このアイテムを表示する:本文(pdf) ( 1.1MB) ダウンロード回数:
回
このアイテムを表示する:URI